Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 19 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 19 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Infographic – Public Favors Rejoining Paris Accord

Chart: rejoin Paris accord?

A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agreement. . . . → Read More: Infographic – Public Favors Rejoining Paris Accord

Trial Requested for Covid-19 Vaccine Nasal Spray

Nasal spray

Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray

FDA Grants Emergency Clearance for Home Covid-19 Test

Lucira test

The Food and Drug Administration gave an emergency authorization for a self-collected Covid-19 diagnostic test, the first such test for home use. . . . → Read More: FDA Grants Emergency Clearance for Home Covid-19 Test

ALS Stem Cell Therapy Fails to Meet Trial Objective

Neurons

Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective

Infographic: U.S. Public Supports Lockdown

Chart: support for lockdowns

With Covid-19 cases in the U.S. accelerating in the past few weeks, a recent poll shows the public clearly favors a lockdown to stop the rise. . . . → Read More: Infographic: U.S. Public Supports Lockdown

Covid-19 Saliva Test Earns FDA Emergency Clearance

SARS-Cov-2 viruses

A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration. . . . → Read More: Covid-19 Saliva Test Earns FDA Emergency Clearance

FDA Issues Guidance to Boost Clinical Trial Diversity

Medical gear

Food and Drug Administration issued new regulatory guidance designed to enroll clinical trial participants more representative of the populations they claim to serve. . . . → Read More: FDA Issues Guidance to Boost Clinical Trial Diversity

Infographic – U.S. Public Split on Contact Tracing

Contact tracing survey

While majorities of Americans say they’re willing to take part in contact tracing activities during the Covid-19 pandemic, large parts of the public are still reluctant. . . . → Read More: Infographic – U.S. Public Split on Contact Tracing

FDA to Use Lung Chip Model for Covid-19 Testing

Emulate lung chip

The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes. . . . → Read More: FDA to Use Lung Chip Model for Covid-19 Testing

Lilly, NIH Halt Covid-19 Antibody Therapy Trial

Stop signs graphic

Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial